Estrogen receptor-β status influences clinical outcome of triple-negative breast cancer

Goi Sakamoto; Naoko Honma

首页> 外文期刊>Breast Cancer >Estrogen receptor-β status influences clinical outcome of triple-negative breast cancer

【24h】

Estrogen receptor-β status influences clinical outcome of triple-negative breast cancer

机译：雌激素受体-β状态影响三阴性乳腺癌的临床结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

In this conference paper, we show that estrogen receptor-β status influences clinical outcome of triple-negative breast cancer referring two of our recent research articles.

机译：在本次会议论文中，我们引用了我们最近的两篇研究文章，表明雌激素受体-β状态会影响三阴性乳腺癌的临床结局。

著录项

来源
《Breast Cancer》 |2009年第4期|281-282|共2页
作者
Goi Sakamoto; Naoko Honma;
展开▼
作者单位

Sakamoto Memorial Clinic Academy of Breast Pathology 2-1-3 Ichigaya Tamachi Shinjuku-ku Tokyo 162-0843 Japan;

Research Team for Geriatric Diseases Tokyo Metropolitan Institute of Gerontology 35-2 Sakae-cho Itabashi-ku Tokyo 173-0015 Japan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
Estrogen receptor-β; Triple-negative breast cancer;

机译：雌激素受体-β;三阴性乳腺癌;

相似文献

外文文献
中文文献
专利

1. Estrogen receptor-β: why may it influence clinical outcome in estrogen receptor-α positive breast cancer? [J] . Margaret A Shupnik Breast Cancer Research . 2007,第3期

机译：雌激素受体-β：为什么会影响雌激素受体-α阳性乳腺癌的临床结局？
2. Estrogen receptor-β: why may it influence clinical outcome in estrogen receptor-α positive breast cancer? [J] . Margaret A Shupnik Breast Cancer Research . 2007,第3期

机译：雌激素受体-β：为什么会影响雌激素受体-α阳性乳腺癌的临床结局？
3. Biologic Roles of Estrogen Receptor-β and Insulin-Like Growth Factor-2 in Triple-Negative Breast Cancer [J] . Nalo Hamilton, Diana Marquez-Garban, Vei Mah, BioMed research international . 2015,第13期

机译：雌激素受体-β和胰岛素样生长因子-2的生物学作用在三阴性乳腺癌中
4. Study on Molecular Docking of Red Betel (Piper Crocatum Ruiz Pav.) Active Compound and Tamoxifen Drug as an Inhibitor of Estrogen Receptor-α (ER-α) that Plays a Role in Breast Cancer [C] . Siti Imroatul Maslikah, Sri Rahayu Lestari, Nursasi Handayani, International Conference on Life Sciences and Technology . 2020

机译：红色槟榔（吹笛茶叶ruiz＆pav.）活性化合物和三氧化物药物作为发挥乳腺癌作用的雌激素受体-α（ER-α）抑制剂的研究
5. Mechanisms of Action and Efficacy Modulation of Novel Retinoic Acid Metabolism Blocking Agent (RAMBA) VN/12-1 in Estrogen Receptor-α Negative Breast Cancer Model Systems: Targeting Autophagy [D] . Godbole, Abhijit Moreshwar 2011

机译：新型视黄酸代谢阻断剂（RAMBA）VN / 12-1在雌激素受体-α阴性乳腺癌模型系统中的作用和功效调节机制：靶向自噬
6. Estrogen receptor-β: why may it influence clinical outcome in estrogen receptor-α positive breast cancer? [O] . Margaret A Shupnik 2007

机译：雌激素受体-β：为什么会影响雌激素受体-α阳性乳腺癌的临床结局？
7. Estrogen receptor-β: why may it influence clinical outcome in estrogen receptor-α positive breast cancer? [O] . Shupnik, Margaret A 2007

机译：雌激素受体-β：为什么会影响雌激素受体-α阳性乳腺癌的临床结局？

Estrogen receptor-β status influences clinical outcome of triple-negative breast cancer

摘要

著录项

相似文献

相关主题

期刊订阅